Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corp (NMTC)
Filing Type: Form 8-K (Current Report)
Report Date: May 12, 2026
Reporting Period: Fiscal quarter ended March 31, 2026
Context: The filing announces the issuance of a press release detailing financial results for the quarter ended March 31, 2026. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are located in the referenced press release (Exhibit 99.1), which is not included in the input text.
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific data to compare against prior periods. It only confirms that results for the quarter ended March 31, 2026, have been announced.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. These items are expected to be detailed in the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 12, 2026) for actual financial figures.
- Verify the specific revenue and net income/loss for the quarter ended March 31, 2026.
- Check for any updated guidance or operational milestones mentioned in the press release.
- Confirm the status of the company's cash position and liquidity as reported in the full release.